RPReenal Pattni

Reenal Pattni

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Reenal Pattni has a total of 90 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers

    Hyperexcitable arousal circuits drive sleep instability during aging

    by Shi-Bin Li, Valentina Martinez Damonte, Chong Chen, Gordon X. Wang, Justus M. Kebschull, Hiroshi Yamaguchi, Wen-Jie Bian, Carolin Purmann, Reenal Pattni, Alexander Eckehart Urban, et al.

    Sleep quality declines with age; however, the underlying mechanisms remain elusive. We found that hyperexcitable hypocretin/orexin (Hcrt/OX) neurons drive sleep fragmentation during aging. In aged mice, Hcrt neurons exhibited more frequent neuronal activity epochs driving wake bouts, and optogenetic activation of Hcrt neurons elicited more prolonged wakefulness. Aged Hcrt neurons showed hyperexcitability with lower KCNQ2 expression and impaired M-current, mediated by KCNQ2/3 channels. Single-nucleus RNA-sequencing revealed adaptive changes to Hcrt neuron loss in the aging brain. Disruption of Kcnq2/3 genes in Hcrt neurons of young mice destabilized sleep, mimicking aging-associated sleep fragmentation, whereas the KCNQ-selective activator flupirtine hyperpolarized Hcrt neurons and rejuvenated sleep architecture in aged mice. Our findings demonstrate a mechanism underlying sleep instability during aging and a strategy to improve sleep continuity.


  • Open Access

    Haplotype-resolved and integrated genome analysis of the cancer cell line HepG2

    by Bo Zhou, Steve S Ho, Stephanie U Greer, Noah Spies, John M Bell, Xianglong Zhang, Xiaowei Zhu, Joseph G Arthur, Seunggyu Byeon, Reenal Pattni, et al.

    HepG2 is one of the most widely used human cancer cell lines in biomedical research and one of the main cell lines of ENCODE. Although the functional genomic and epigenomic characteristics of HepG2 are extensively studied, its genome sequence has never been comprehensively analyzed and higher order genomic structural features are largely unknown. The high degree of aneuploidy in HepG2 renders traditional genome variant analysis methods challenging and partially ineffective. Correct and complete interpretation of the extensive functional genomics data from HepG2 requires an understanding of the cell line’s genome sequence and genome structure. Using a variety of sequencing and analysis methods, we identified a wide spectrum of genome characteristics in HepG2: copy numbers of chromosomal segments at high resolution, SNVs and Indels (corrected for aneuploidy), regions with loss of heterozygosity, phased haplotypes extending to entire chromosome arms, retrotransposon insertions and structural variants (SVs) including complex and somatic genomic rearrangements. A large number of SVs were phased, sequence assembled and experimentally validated. We re-analyzed published HepG2 datasets for allele-specific expression and DNA methylation and assembled an allele-specific CRISPR/Cas9 targeting map. We demonstrate how deeper insights into genomic regulatory complexity are gained by adopting a genome-integrated framework.


  • Open Access

    Comprehensive, integrated, and phased whole-genome analysis of the primary ENCODE cell line K562

    by Bo Zhou, Steve S. Ho, Stephanie U. Greer, Xiaowei Zhu, John M. Bell, Joseph G. Arthur, Noah Spies, Xianglong Zhang, Seunggyu Byeon, Reenal Pattni, et al.

    K562 is widely used in biomedical research. It is one of three tier-one cell lines of ENCODE and also most commonly used for large-scale CRISPR/Cas9 screens. Although its functional genomic and epigenomic characteristics have been extensively studied, its genome sequence and genomic structural features have never been comprehensively analyzed. Such information is essential for the correct interpretation and understanding of the vast troves of existing functional genomics and epigenomics data for K562. We performed and integrated deep-coverage whole-genome (short-insert), mate-pair, and linked-read sequencing as well as karyotyping and array CGH analysis to identify a wide spectrum of genome characteristics in K562: copy numbers (CN) of aneuploid chromosome segments at high-resolution, SNVs and indels (both corrected for CN in aneuploid regions), loss of heterozygosity, megabase-scale phased haplotypes often spanning entire chromosome arms, structural variants (SVs), including small and large-scale complex SVs and nonreference retrotransposon insertions. Many SVs were phased, assembled, and experimentally validated. We identified multiple allele-specific deletions and duplications within the tumor suppressor gene FHIT. Taking aneuploidy into account, we reanalyzed K562 RNA-seq and whole-genome bisulfite sequencing data for allele-specific expression and allele-specific DNA methylation. We also show examples of how deeper insights into regulatory complexity are gained by integrating genomic variant information and structural context with functional genomics and epigenomics data. Furthermore, using K562 haplotype information, we produced an allele-specific CRISPR targeting map. This comprehensive whole-genome analysis serves as a resource for future studies that utilize K562 as well as a framework for the analysis of other cancer genomes.


  • Open Access

    Extensive and deep sequencing of the Venter/HuRef genome for developing and benchmarking genome analysis tools

    by Bo Zhou, Joseph G. Arthur, Steve S. Ho, Reenal Pattni, Yiling Huang, Wing H. Wong, Alexander E. Urban

    We produced an extensive collection of deep re-sequencing datasets for the Venter/HuRef genome using the Illumina massively-parallel DNA sequencing platform. The original Venter genome sequence is a very-high quality phased assembly based on Sanger sequencing. Therefore, researchers developing novel computational tools for the analysis of human genome sequence variation for the dominant Illumina sequencing technology can test and hone their algorithms by making variant calls from these Venter/HuRef datasets and then immediately confirm the detected variants in the Sanger assembly, freeing them of the need for further experimental validation. This process also applies to implementing and benchmarking existing genome analysis pipelines. We prepared and sequenced 200 bp and 350 bp short-insert whole-genome sequencing libraries (sequenced to 100x and 40x genomic coverages respectively) as well as 2 kb, 5 kb, and 12 kb mate-pair libraries (49x, 122x, and 145x physical coverages respectively). Lastly, we produced a linked-read library (128x physical coverage) from which we also performed haplotype phasing.


  • Open Access

    Haplotype-resolved and integrated genome analysis of the cancer cell line HepG2

    by Bo Zhou, Steve S. Ho, Stephanie U. Greer, Noah Spies, John M. Bell, Xianglong Zhang, Xiaowei Zhu, Joseph G. Arthur, Seunggyu Byeon, Reenal Pattni, et al.

    SUMMARY: The HepG2 cancer cell line is one of the most widely-used biomedical research and one of the main cell lines of ENCODE. Vast numbers of functional genomics and epigenomics datasets have been produced to characterize its biology. However, the correct interpretation such data requires an understanding of the cell line’s genome sequence and genome structure. Using a variety of sequencing and analysis methods, we identified a wide spectrum of HepG2 genome characteristics: copy numbers of chromosomal segments, SNVs and Indels (corrected for aneuploidy), phased haplotypes extending to entire chromosome arms, loss of heterozygosity, retrotransposon insertions, structural variants (SVs) including complex and somatic genomic rearrangements. We also identified allele-specific expression and DNA methylation genome-wide and assembled an allele-specific CRISPR/Cas9 targeting map. SIGNIFICANCE: Haplotype-resolved and comprehensive whole-genome analysis of a widely-used cell line for cancer research and ENCODE, HepG2, serves as an essential resource for unlocking complex cancer gene regulation using a genome-integrated framework and also provides genomic context for the analysis of ~1,000 functional datasets to date on ENCODE for biological discovery. We also demonstrate how deeper insights into genomic regulatory complexity are gained by adopting a genome-integrated framework.


  • Open Access

    Extensive and deep sequencing of the Venter/HuRef genome for developing and benchmarking genome analysis tools

    by Bo Zhou, Joseph G. Arthur, Steve S. Ho, Reenal Pattni, Yiling Huang, Wing H. Wong, Alexander E. Urban

    We produced an extensive collection of deep re-sequencing datasets for the Venter/HuRef genome using the Illumina massively-parallel DNA sequencing platform. The original Venter genome sequence is a very-high quality phased assembly based on Sanger sequencing. Therefore, researchers developing novel computational tools for the analysis of human genome sequence variation for the dominant Illumina sequencing technology can test and hone their algorithms by making variant calls from these Venter/HuRef datasets and then immediately confirm the detected variants in the Sanger assembly, freeing them of the need for further experimental validation. This process also applies to implementing and benchmarking existing genome analysis pipelines. We prepared and sequenced 200 bp and 350 bp short-insert whole-genome sequencing libraries (sequenced to 100x and 40x genomic coverages respectively) as well as 2 kb, 5 kb, and 12 kb mate-pair libraries (49x, 122x, and 145x physical coverages respectively). Lastly, we produced a linked-read library (128x physical coverage) from which we also performed haplotype phasing.

  • Top Cited Papers

    Different mutational rates and mechanisms in human cells at pregastrulation and neurogenesis

    by Taejeong Bae, Livia Tomasini, Jessica Mariani, Bo Zhou, Tanmoy Roychowdhury, Daniel Franjic, Mihovil Pletikos, Reenal Pattni, Bo-Juen Chen, Elisa Venturini, et al.

    Brain mutations, young and old: Most neurons that make up the human brain are postmitotic, living and functioning for a very long time without renewal (see the Perspective by Lee). Bae et al. examined the genomes of single neurons from the prenatal developing human brain. Both the type of mutation and the rates of accumulation changed between gastrulation and neurogenesis. These early mutations could be generating useful neuronal diversity or could predispose individuals to later dysfunction. Lodato et al. also found that neurons take on somatic mutations as they age by sequencing single neurons from subjects aged 4 months to 82 years. Somatic mutations accumulated with increasing age and accumulated faster in individuals affected by inborn errors in DNA repair. Postmitotic mutations might only affect one neuron, but the accumulated divergence of genomes across the brain could affect function. Science , this issue p. 550 , p. 555 ; see also p. 521


  • Open Access

    Comprehensive, integrated, and phased whole-genome analysis of the primary ENCODE cell line K562

    by Bo Zhou, Steve S. Ho, Stephanie U. Greer, Xiaowei Zhu, John M. Bell, Joseph G. Arthur, Noah Spies, Xianglong Zhang, Seunggyu Byeon, Reenal Pattni, et al.

    K562 is widely used in biomedical research. It is one of three tier-one cell lines of ENCODE and also most commonly used for large-scale CRISPR/Cas9 screens. Although its functional genomic and epigenomic characteristics have been extensively studied, its genome sequence and genomic structural features have never been comprehensively analyzed. Such information is essential for the correct interpretation and understanding of the vast troves of existing functional genomics and epigenomics data for K562. We performed and integrated deep-coverage whole-genome (short-insert), mate-pair, and linked-read sequencing as well as karyotyping and array CGH analysis to identify a wide spectrum of genome characteristics in K562: copy numbers (CN) of aneuploid chromosome segments at high-resolution, SNVs and Indels (both corrected for CN in aneuploid regions), loss of heterozygosity, mega-base-scale phased haplotypes often spanning entire chromosome arms, structural variants (SVs) including small and large-scale complex SVs and non-reference retrotransposon insertions. Many SVs were phased, assembled, and experimentally validated. We identified multiple allele-specific deletions and duplications within the tumor suppressor gene FHIT . Taking aneuploidy into account, we re-analyzed K562 RNA-seq and whole-genome bisulfite sequencing data for allele-specific expression and allele-specific DNA methylation. We also show examples of how deeper insights into regulatory complexity are gained by integrating genomic variant information and structural context with functional genomics and epigenomics data. Furthermore, using K562 haplotype information, we produced an allele-specific CRISPR targeting map. This comprehensive whole-genome analysis serves as a resource for future studies that utilize K562 as well as a framework for the analysis of other cancer genomes.


  • Open Access

    Whole-genome sequencing analysis of copy number variation (CNV) using low-coverage and paired-end strategies is efficient and outperforms array-based CNV analysis

    by Bo Zhou, Steve S. Ho, Xianglong Zhang, Reenal Pattni, Rajini R. Haraksingh, Alexander E. Urban

    Background: CNV analysis is an integral component to the study of human genomes in both research and clinical settings. Array-based CNV analysis is the current first-tier approach in clinical cytogenetics. Decreasing costs in high-throughput sequencing and cloud computing have opened doors for the development of sequencing-based CNV analysis pipelines with fast turnaround times. We carry out a systematic and quantitative comparative analysis for several low-coverage whole-genome sequencing (WGS) strategies to detect CNV in the human genome. Methods: We compared the CNV detection capabilities of WGS strategies (short-insert, 3kb-, and 5kb-insert mate-pair) each at 1x, 3x, and 5x coverages relative to each other and to 17 currently used high-density oligonucleotide arrays. For benchmarking, we used a set of Gold Standard (GS) CNVs generated for the 1000-Genomes-Project CEU subject NA12878. Results: Overall, low-coverage WGS strategies detect drastically more GS CNVs compared to arrays and are accompanied with smaller percentages of CNV calls without validation. Furthermore, we show that WGS (at ≥1x coverage) is able to detect all seven GS deletion-CNVs >100 kb in NA12878 whereas only one is detected by most arrays. Lastly, we show that the much larger 15 Mbp Cri-du-chat deletion can be readily detected with short-insert paired-end WGS at even just 1x coverage. Conclusions: CNV analysis using low-coverage WGS is efficient and outperforms the array-based analysis that is currently used for clinical cytogenetics.


  • Open Access

    Automatic detection of complex structural genome variation across world populations

    by Bo Zhou, Joseph G. Arthur, Hanmin Guo, Christopher R. Hughes, Taeyoung Kim, Yiling Huang, Reenal Pattni, HoJoon Lee, Hanlee P. Ji, Giltae Song, et al.

    Complex structural variants (cxSVs), e.g. inversions with flanking deletions or interspersed inverted duplications, are part of human genetic diversity but their characteristics are not well delineated. Because their structures are difficult to resolve, cxSVs have been largely excluded from genome analysis and population-scale association studies. To permit large-scale detection of cxSVs from paired-end whole-genome sequencing, we developed Automated Reconstruction of Complex Variants (ARC-SV) using a novel probabilistic algorithm and a machine learning approach that leverages the new Human Pangenome Reference Consortium diploid assemblies. Using ARC-SV, we resolved, across 4,262 human genomes spanning all continental super-populations, 8,493 cxSVs belonging to 12 subclasses. Some cxSVs with population-specific signatures are shared with Neanderthals. Overall cxSVs are significantly enriched in regions prone to recombination and germline de novo mutations. Many cxSVs mark phenotypic hotspots (each significantly associated with ≥ 20 traits) identified in genome-wide association studies (GWAS), and 46.4% of all significant GWAS-SNPs catalogued to date reside within ±125 kb of at least one cxSV locus. Common SNPs near cxSVs show significant trait heritability enrichment. Genomic regions affected by cxSVs are enriched for bivalent chromatin states. Rare cxSVs are enriched in neural genes and loci undergoing rapid or accelerated evolution and recently evolved cis -regulatory regions for human corticogenesis. We also identified 41 fixed loci where divergence from our most recent common ancestor is via localized cxSV. Our method and analysis framework allow for the accurate, efficient, and automatic identification of cxSVs for future population-scale studies of human disease and genome biology.